Vera Therapeutics’ Trutakna Stabilizes Kidney Function in Phase 3 IgAN Trial
Vera Therapeutics announced final two-year Phase 3 trial results for its newly approved drug Trutakna, demonstrating sustained kidney function stabilization and a reduced risk of kidney-related death and other complications ... Read More